USPTO serial 76392543
GLISSIVA
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- COFIELD, JULIA
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with GLISSIVA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
MADISON, NJ
Indianapolis, IN
Indianapolis, IN
CORONA, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
STEPHANIE K WADE
STEPHANIE K WADE DICKSTEIN SHAPIRO MORIN & OSHINSKY LLP2101 ST NWWASHINGTON, DC 20037UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | pharmaceutical preparations, namely pharmaceutical preparations for the treatment and prevention of blood disorders, cancer, cardiovascular diseases, dermatological disorders, diabetic neuropathy, endocrine disorders, gastrointestinal disorders, hormonal diseases and disorders, immunological, bacterial, viral and fungal disorders, infectious diseases, inflammations and inflammatory diseases, musculoskeletal disorders, neurodegenerative disorders, neurological disorders, obesity, ophthalmologic conditions and diseases, pain, peripheral nervous system diseases and disorders, reproductive disorders, sexual dysfunction, sepsis, urological disorders | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by ALLERGAN SALES, LLC
- Other trademarks owned by Eli Lilly and Company
- Other trademarks owned by Eli Lilly and Company
- Other trademarks owned by WATSON PHARMACEUTICALS, INC.
- Other trademarks in Class 005
- Similar marks named GLISSIVA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 3, 2018 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Mar 29, 2006 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Mar 29, 2006 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jun 15, 2005 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Jun 15, 2005 | EXT5 | SOU EXTENSION 5 FILED | — |
| Jun 15, 2005 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 15, 2005 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 13, 2004 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Nov 19, 2004 | EXT4 | SOU EXTENSION 4 FILED | — |
| Nov 19, 2004 | PAPER RECEIVED | — | |
| Jun 9, 2004 | EX3G | SOU EXTENSION 3 GRANTED | — |
| May 27, 2004 | CFIT | CASE FILE IN TICRS | — |
| May 18, 2004 | EXT3 | SOU EXTENSION 3 FILED | — |
| May 18, 2004 | PAPER RECEIVED | — | |
| Feb 5, 2004 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jan 9, 2004 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jan 9, 2004 | PAPER RECEIVED | — | |
| Sep 8, 2003 | PAPER RECEIVED | — | |
| Aug 13, 2003 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jul 21, 2003 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jul 21, 2003 | PAPER RECEIVED | — | |
| Jan 21, 2003 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Oct 29, 2002 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 9, 2002 | NPUB | NOTICE OF PUBLICATION | — |
| Aug 12, 2002 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 5, 2002 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 1, 2002 | DOCK | ASSIGNED TO EXAMINER | — |